Published on
Apr 16, 2025
Vertex’s Attempt to Redefine AKS Falls Short: Key Insights for Pharma Manufacturers
In a series of recent legal challenges initiated by the pharmaceutical industry against the US Department of Health and Human Services Office of the Inspector General (OIG), manufacturers have contested the OIG’s long-standing interpretation of the Anti- …
Source:
JD Supra - California
-
Neutral
)
